pimonidazole has been researched along with Prostatic Neoplasms in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gaffney, J; Hompland, T; Leech, M; Leijenaar, RTH; Lyng, H; Marignol, L | 1 |
Axcrona, K; Frikstad, KM; Hole, KH; Julin, CH; Lie, AK; Lyng, H; Ragnum, HB; Seierstad, T; Vlatkovic, L | 1 |
Ackerstaff, E; Carlin, S; Cho, H; Humm, JL; Koutcher, JA; Ling, CC; Lupu, ME; O'Donoghue, J; Rizwan, A; Wang, Y; Zanzonico, PB | 1 |
Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Jung, SM; Lee, CC; Tsai, CS; Wang, CC; Wen, CJ | 1 |
Hagtvet, E; Olsen, DR; Røe, K | 1 |
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S | 1 |
Bentzen, SM; Carnell, DM; Daley, FM; Hoskin, PJ; Saunders, MI; Smith, RE | 1 |
Bentzen, SM; Carnell, DM; Collins, DJ; d'Arcy, JA; Daley, FM; Hoskin, PJ; Padhani, AP; Saunders, MI; Smith, RE; Stirling, JJ; Taylor, NJ | 1 |
8 other study(ies) available for pimonidazole and Prostatic Neoplasms
Article | Year |
---|---|
Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring.
Topics: Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Prostate; Prostatic Neoplasms; Retrospective Studies | 2023 |
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.
Topics: Cell Hypoxia; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Nitroimidazoles; Proportional Hazards Models; Prostatic Neoplasms; Staining and Labeling; Tissue Distribution; Transcriptome | 2015 |
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Disease Models, Animal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats | 2009 |
Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Aggregation; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Drug Resistance, Neoplasm; Endothelial Cells; Green Fluorescent Proteins; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Nitroimidazoles; Prostatic Neoplasms; Pyrroles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Salvage Therapy; Sunitinib; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2011 |
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; Contrast Media; Doxorubicin; Humans; Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Theoretical; Neoplasm Transplantation; Nitroimidazoles; Prostatic Neoplasms; Treatment Outcome | 2011 |
Dependence of FDG uptake on tumor microenvironment.
Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals | 2005 |
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Cell Hypoxia; Humans; Immunohistochemistry; Male; Middle Aged; Nitroimidazoles; Prostatic Neoplasms; Radiation-Sensitizing Agents | 2006 |
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.
Topics: Aged; Cell Hypoxia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Oxygen; Prostatectomy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Staining and Labeling | 2007 |